Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression

Código QR

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression

Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou, Hongjuan Dong Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaCorrespondence: Hongjuan DongDepartment of Neurology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wucha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yin B, Peng B, Luo Y, Fan S, Xiao T, Zou X, Dong H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	botulinum toxin type a repetitive transcranial magnetic stimulation anxiety/depression disorder benign essential blepharospasm Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/70e3636d5bc841b7b18276c3516fbb6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong H, et al.
Publicado: (2018)

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jeongkyeong Jang, et al.
Publicado: (2021)

Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use
por: Nastaran Namazi, et al.
Publicado: (2016)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
por: Allameh F, et al.
Publicado: (2020)

Depression in blepharospasm: a question of facial feedback?
por: Bedarf JR, et al.
Publicado: (2017)

Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation
por: A.M. Heath, et al.
Publicado: (2022)

New trends in botulinum toxin use in dermatology
por: Stefania Guida, et al.
Publicado: (2018)

The Efficacy of Dose Increments of Botulinum Toxin A in the Treatment of Childhood Esotropia
por: Alshamlan FT, et al.
Publicado: (2021)

True-Color Face Peeled Images with Botulinum Toxin Injection Sites and Anatomic Landmarks
por: Park,Jin Seo, et al.
Publicado: (2019)

Bilateral Orbitofrontal Repetitive Transcranial Magnetic Stimulation in Frontal Lobe Epilepsy: A Case Report
por: Georgios Mikellides, et al.
Publicado: (2021)

Subthreshold repetitive transcranial magnetic stimulation drives structural synaptic plasticity in the young and aged motor cortex
por: Alexander D. Tang, et al.
Publicado: (2021)

Difference in Analgesic Effects of Repetitive Transcranial Magnetic Stimulation According to the Site of Pain
por: Nobuhiko Mori, et al.
Publicado: (2021)

Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan
por: Ryuji Kaji, et al.
Publicado: (2021)

Localization of the Centers of Intramuscular Nerve Dense Regions of the Rotator Cuff Muscles: A Guide for Botulinum Toxin A Injection for Spasticity Accompanied by Shoulder Pain
por: Luo,Huaixiang, et al.
Publicado: (2020)

Effect of Pulse Duration and Direction on Plasticity Induced by 5 Hz Repetitive Transcranial Magnetic Stimulation in Correlation With Neuronal Depolarization
por: Islam Halawa, et al.
Publicado: (2021)

Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified <named-content content-type="genus-species">Clostridium botulinum</named-content> Strain
por: Sabine Pellett, et al.
Publicado: (2016)

The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes
por: Sabine Pellett, et al.
Publicado: (2018)

Predictive Role of Executive Function in the Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation Modalities for Treating Methamphetamine Use Disorder—A Randomized Clinical Trial
por: Li-Jin Wang, et al.
Publicado: (2021)

Effectiveness and Safety of Botulinum Toxin Type A in Treatment of Restless Legs Syndrome: A Systematic Review and Meta-Analysis
por: Yu-Chi Su, et al.
Publicado: (2021)

Adjuvant treatment with repetitive transcranial magnetic stimulation in freshly diagnosed alcohol-dependence syndrome patients from an industry: An outcome study
por: Anindya Kumar Gupta, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study
por: Antczak J, et al.
Publicado: (2018)

Using Transcranial Electrical Stimulation in Audiological Practice: The Gaps to Be Filled
por: Mujda Nooristani, et al.
Publicado: (2021)

Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review
por: Stultz DJ, et al.
Publicado: (2020)

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A
por: Jariyakosol S, et al.
Publicado: (2021)

Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): a pilot study
por: Knyahnytska YO, et al.
Publicado: (2019)

Neuronavigation-guided high-dose repetitive transcranial magnetic stimulation for the treatment of depressive adolescents with suicidal ideation: a case series
por: Pan F, et al.
Publicado: (2018)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
por: Cao P, et al.
Publicado: (2018)

Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins
por: Toshiaki Takeuchi, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation in trauma-related conditions
por: Namgung E, et al.
Publicado: (2019)

Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: a meta-analysis of randomized, controlled clinical trials
por: Qin B, et al.
Publicado: (2018)

Editorial: Novel Multimodal Approaches in Non-invasive Brain Stimulation
por: Nivethida Thirugnanasambandam, et al.
Publicado: (2021)

Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
por: Koenraad De Boulle, et al.
Publicado: (2010)

Repetitive Transcranial Magnetic Stimulation for Alzheimer’s Disease Based on Apolipoprotein E Genotyping: Protocol for a Randomized Controlled Study
por: Naili Wei, et al.
Publicado: (2021)

Comparative Study between Intranasal Injection of Botulinum Toxin-A and Combined Intranasal Medical Treatment for Allergic Rhinitis
por: Nabil Sarhan, et al.
Publicado: (2020)

The positive effects of high-frequency right dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation on memory, correlated with increases in brain metabolites detected by proton magnetic resonance spectroscopy in recently detoxified alcohol-dependent patients
por: Qiao J, et al.
Publicado: (2016)

Sexual dysfunction in cervical dystonia and blepharospasm
por: Marek M, et al.
Publicado: (2018)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo K, et al.
Publicado: (2019)

Botulinum Toxin a Injection Combined with Radial Extracorporeal Shock Wave Therapy in Children with Spastic Cerebral Palsy: Shear Wave Sonoelastographic Findings in the Medial Gastrocnemius Muscle, Preliminary Study
por: Dong Rak Kwon, et al.
Publicado: (2021)

A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression: A Canadian rTMS treatment and biomarker network in depression (CARTBIND) study
por: Daniel M. Blumberger, et al.
Publicado: (2021)

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao S, et al.
Publicado: (2017)